Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Demoly

Showing results (81-90 of 367) with videos related to

Pageof 37
Sort By:
Current Opinion in Allergy and Clinical Immunology|June 26, 2023
Drug allergy in primary care: systematic review to support quality improvement initiative of management and optimization of healthcare pathwaysClara Gaudin, Dermot Ryan, Pascal Demoly, et al.
Clinical and Translational Allergy|December 25, 2015
Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dosePascal Demoly, Gianni Passalacqua, Moises A Calderon, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 13, 2016
Severity and disease control before house dust mite immunotherapy initiation: ANTARES a French observational surveyPascal Demoly, Anne Broué-Chabbert, François Wessel, et al.
Allergy|October 5, 2019
Data-driven step doses for drug provocation tests to nonsteroidal anti-inflammatory drugsDunya Nohra, Nicolas Molinari, Pascal Demoly, et al.
Archives of Internal Medicine|July 13, 2005
Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactionsSaid Benahmed, Marie-Christine Picot, Francine Dumas, et al.
Clinical and Translational Allergy|June 10, 2014
Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergensFlorence Trebuchon, Michèle Lhéritier-Barrand, Marie David, et al.
Current Opinion in Allergy and Clinical Immunology|August 13, 2025
Recurrences of anaphylaxis: trends and risk factorsPham Thao Van Luong, Pascal Demoly, Luciana Kase Tanno
Immunology and Allergy Clinics of North America|December 1, 2015
Allergen Immunotherapy Outcomes and Unmet Needs: A Critical ReviewDavide Caimmi, Moises A Calderon, Jean Bousquet, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 20, 2014
Reasons for prescribing second generation antihistamines to treat allergic rhinitis in real-life conditions and patient responsePascal Demoly, Anca Mirela Chiriac, Benoît Berge, et al.
International Archives of Allergy and Immunology|June 29, 2012
How can we better classify NSAID hypersensitivity reactions?--validation from a large databaseSilvia Caimmi, Davide Caimmi, Philippe-Jean Bousquet, et al.
Pageof 37

Showing results (81-90 of 367) with videos related to

Sort By:
Pageof 37
Current Opinion in Allergy and Clinical Immunology|June 26, 2023
Drug allergy in primary care: systematic review to support quality improvement initiative of management and optimization of healthcare pathwaysClara Gaudin, Dermot Ryan, Pascal Demoly, et al.
Clinical and Translational Allergy|December 25, 2015
Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dosePascal Demoly, Gianni Passalacqua, Moises A Calderon, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 13, 2016
Severity and disease control before house dust mite immunotherapy initiation: ANTARES a French observational surveyPascal Demoly, Anne Broué-Chabbert, François Wessel, et al.
Allergy|October 5, 2019
Data-driven step doses for drug provocation tests to nonsteroidal anti-inflammatory drugsDunya Nohra, Nicolas Molinari, Pascal Demoly, et al.
Archives of Internal Medicine|July 13, 2005
Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactionsSaid Benahmed, Marie-Christine Picot, Francine Dumas, et al.
Clinical and Translational Allergy|June 10, 2014
Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergensFlorence Trebuchon, Michèle Lhéritier-Barrand, Marie David, et al.
Current Opinion in Allergy and Clinical Immunology|August 13, 2025
Recurrences of anaphylaxis: trends and risk factorsPham Thao Van Luong, Pascal Demoly, Luciana Kase Tanno
Immunology and Allergy Clinics of North America|December 1, 2015
Allergen Immunotherapy Outcomes and Unmet Needs: A Critical ReviewDavide Caimmi, Moises A Calderon, Jean Bousquet, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 20, 2014
Reasons for prescribing second generation antihistamines to treat allergic rhinitis in real-life conditions and patient responsePascal Demoly, Anca Mirela Chiriac, Benoît Berge, et al.
International Archives of Allergy and Immunology|June 29, 2012
How can we better classify NSAID hypersensitivity reactions?--validation from a large databaseSilvia Caimmi, Davide Caimmi, Philippe-Jean Bousquet, et al.
Pageof 37